
Description of the blood test:
The VDRL test is a classic laboratory screening method used to detect antibodies produced in response to an infection with Treponema pallidum (syphilis). Unlike specific tests that look for the bacteria itself, the VDRL measures “reagin” antibodies—substances produced by the body when its cells are damaged by the infection. This test is highly valued for its ability to reflect the current activity of the disease. Because reagin levels typically drop after successful treatment, the VDRL is the primary tool used by physicians to monitor the effectiveness of therapy and to screen for active stages of the infection.
What does the analysis represent?
Recommendations for the test (General)
What can affect the results?
When to take the test?
How to interpret the results?
The interpretation of data is the exclusive responsibility of an infectious disease specialist, urologist, or dermatovenerologist. A positive VDRL result is a clinical indicator of potential activity but is not a definitive diagnosis of syphilis. The physician evaluates titers together with treponemal tests (TPHA, FTA-ABS) and the clinical picture to confirm disease activity or exclude false-positive reactions.
Possible further investigations
When does the next step make sense?
A positive VDRL result requires medical clarification to exclude false-positive reactions and determine disease stage. A consultation is required to establish accurate diagnosis and treatment strategy.
👉 If necessary, you can discuss the test results with our specialized — urologist (Doctors – TAMC).